"Despite clear congressional mandates and FDA authorization, the Drug Enforcement Administration failed to act within the timelines required by law, resulting in years-long delay of medical cannabis ...

SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its ...

This Christmas season, President Trump's executive action to advance rescheduling and medical research has finally exposed the truth: the DEA marijuana obstruction was never about public safety. It ...

From combination surgeries to advanced skin therapies, The Naderi Center outlines how patients nationwide are prioritizing ...

Expedited Development Enabled by RMAT and Breakthrough Therapy StatusClinical Trial Initiation in 2026, FDA Approval Target ...

ASPS trend reporting highlights facelift combined with eyelid surgery as a leading 2025 combination; national procedure ...

Findings show Linus Health’s AI can indicate Alzheimer’s pathology before noticeable symptoms—enabling earlier action to help protect independence and preserve what makes us who we areBOSTON, December ...

SAN DIEGO, CA / ACCESS Newswire / December 24, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), ...

Weekly Oral Helicase-Primase Inhibitor Programs' Early Data Potentially Supportive of First New Treatment for Recurrent ...

Agreement with the U.S. government addresses prescription drug costs and encourages other wealthy nations to reward ...

Predicting how a person’s heart will respond to a new medicine remains one of the most persistent blind spots in drug ...

Board-certified plastic surgeon and surgeon-scientist honored for clinical excellence, leadership, and commitment to patient ...